4//SEC Filing
KLEIN JOSEPH III 4
Accession 0000874015-25-000220
CIK 0000874015other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 8:38 PM ET
Size
13.6 KB
Accession
0000874015-25-000220
Insider Transaction Report
Form 4
KLEIN JOSEPH III
Director
Transactions
- Sale
Common Stock
2025-09-03$60.00/sh−28,000$1,680,000→ 0 total(indirect: By Trust) - Exercise/Conversion
Common Stock
2025-09-03+12,000→ 28,000 total(indirect: By Trust) - Exercise/Conversion
Common Stock
2025-09-03+16,000→ 16,000 total(indirect: By Trust) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-09-03−12,000→ 0 total(indirect: By Trust)Exercise: $42.88From: 2019-07-02Exp: 2028-07-01→ Common Stock (12,000 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-09-03−16,000→ 0 total(indirect: By Trust)Exercise: $52.22From: 2018-07-03Exp: 2027-07-02→ Common Stock (16,000 underlying)
Holdings
- 100(indirect: by Son)
Common Stock
- 16,346
Common Stock
Footnotes (2)
- [F1]Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on January 3, 2024
- [F2]The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001206369
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 8:38 PM ET
- Size
- 13.6 KB